This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Jiangsu Mingma Biotech Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovator Spotlight: Jiangning Chen and His Contributions to Medical Diagnostics
Introduction: Jiangning Chen is a renowned inventor based in Jiangsu, China, recognized for his innovative contributions to the field of medical diagnostics. With a total of two patents to his name, Chen's work focuses on the evaluation of physiological and pathological conditions through advanced microRNA technologies.
Latest Patents: Jiangning Chen's latest patent, titled "Serum/plasma MicroRNAs and uses thereof," provides a groundbreaking combination of microRNAs that aid in evaluating the physiological and/or pathological conditions of subjects. This invention encompasses a method for determining these microRNAs in serum/plasma, a comprehensive kit for evaluation, and a specialized biochip designed to identify microRNA components. The technologies outlined in this patent can be utilized for diagnosing various diseases, including tumors and infectious diseases, while also offering advantages such as high sensitivity, convenience in sampling, and cost-effectiveness. This innovative approach significantly enhances the clinical detection rate of diseases, paving the way for earlier diagnosis and improved patient outcomes.
Career Highlights: Jiangning Chen is currently associated with Jiangsu Mingma Biotech Co., Ltd., where he continues to push the boundaries of medical technology. His commitment to research and innovation is evident through his patent contributions, which focus on advanced diagnostic methodologies that hold great promise for the healthcare sector.
Collaborations: Throughout his career, Jiangning has collaborated with notable peers including Chenyu Zhang and Junfeng Zhang. These collaborations have played a pivotal role in advancing the research and development of microRNA-based diagnostic tools, fostering an environment of innovation and scientific inquiry.
Conclusion: Jiangning Chen's work exemplifies the transformative power of innovation in medical diagnostics. His patented technologies offer significant advancements in the evaluation of health conditions, demonstrating the potential for early diagnosis and effective disease management. As he continues to innovate, Chen serves as an inspiration to aspiring inventors and researchers in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile